Neoplastic component
|
Cell distribution | Dispersed | Within the nodules | Dispersed |
L&H/L&H-like cells | −/+ | +/− | − |
RS/RS-like cells | −/+ | −/+ | − |
CD45 expression | + | + | − |
CD30 expression | −* | −* | + |
CD15 expression | − | − | +/− |
CD79a expression | +/− | −/+ | −/+ Variable |
CD20 expression | +† | +† | −/+ Variable |
BOB.1 expression | + | + | − |
Oct2 expression | +‡ | +‡ | Rare |
CD3 expression | − | − | −/+ |
EMA expression | +/− | +/− | Rare |
J chain expression | +/− | +/− | − |
MIB-1/Ki-67 expression | High | High | High |
EBV | − | − | + Variable |
Ig gene rearrangement | + | + | +§ |
Reactive component
|
T cells | Numerous | Moderate | Variable |
T cells with irregular nuclear profile | +/− | − | −/+ |
Bcl-6+/CD57+ rosettes | − | Numerous | − |
Amount of TIA-1+ cells | Very high | Low | High |
Amount of CD20+ small lymphocytes | Low | High | Low |
Histiocytes | Variable | Some | Variable |
FDC | − | + | + |
Clinical findings
|
Stage | III/IV | I/II | I/III |
Bone marrow involvement | +/− | − | − |
Orderly progression in the spread | − | − | + |